GetTopicDetailResponse(id=350e89e479a, topicName=血管緊張素Ⅱ受體拮抗劑, introduction=血管緊張素Ⅱ受體拮抗劑, content=null, image=null, comments=0, allHits=1271, url=https://h5.medsci.cn/topic?id=89747, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=24514, tagList=[TagDto(tagId=24514, tagName=血管緊張素Ⅱ受體拮抗劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2189919, encodeId=dba7218991948, content=<a href='/topic/show?id=c24e2e2076' target=_blank style='color:#2F92EE;'>#ARB#</a> <a href='/topic/show?id=350e89e479a' target=_blank style='color:#2F92EE;'>#血管緊張素Ⅱ受體拮抗劑#</a>, objectTitle=從特點到應(yīng)用，盤點臨床常見的血管緊張素Ⅱ受體拮抗劑（ARB）, objectType=article, longId=814690, objectId=d53f81469042, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/pexels-photo-3873143.jpeg, objectUrl=/article/show_article.do?id=d53f81469042, replyNumber=0, likeNumber=128, createdTime=2024-02-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d53f81469042, moduleTitle=從特點到應(yīng)用，盤點臨床常見的血管緊張素Ⅱ受體拮抗劑（ARB）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d53f81469042)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
